PERFORMANCE OF INDICATORS USED IN THE REGULAR RISK ASSESSMENT FOR COVID-19

Intro: Since November 2021, gradual changes in non-pharmaceutical interventions (NPI) had begun in consideration of the socio-economic cost and the high rate of COVID-19 vaccination. As an effort to monitor the COVID-19 situation and the effect of NPIs, regular risk assessment for COVID-19 has been...

Full description

Bibliographic Details
Main Authors: S. Hong, B.I. Kim, J. Oh, M. Lee, H. Kim, S. Tak
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223004861